Literature DB >> 16854520

Testosterone Deficiency Syndrome (TDS) needs to be named appropriately--the importance of accurate terminology.

Alvaro Morales, Claude C Schulman, Jacques Tostain, Frederick C W Wu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16854520     DOI： 10.1016/j.eururo.2006.07.001

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  14 in total

Review 1.  [Therapy of male hypogonadism].

Authors:  M Zitzmann
Journal:  Internist (Berl)       Date:  2008-05       Impact factor: 0.743

Review 2.  Androgens are fundamental in the maintenance of male sexual health.

Authors:  Alvaro Morales
Journal:  Curr Urol Rep       Date:  2011-12       Impact factor: 3.092

Review 3.  Testosterone Therapy in Men With Prostate Cancer.

Authors:  Alan L Kaplan; Jim C Hu; Abraham Morgentaler; John P Mulhall; Claude C Schulman; Francesco Montorsi
Journal:  Eur Urol       Date:  2015-12-21       Impact factor: 20.096

Review 4.  Recent topics related to testosterone deficiency syndrome in Japan.

Authors:  Akira Tsujimura; Norio Nonomura
Journal:  Asian J Androl       Date:  2011-04-04       Impact factor: 3.285

Review 5.  A practical guide to male hypogonadism in the primary care setting.

Authors:  P Dandona; M T Rosenberg
Journal:  Int J Clin Pract       Date:  2010-05       Impact factor: 2.503

6.  How to define hypogonadism? Results from a population of men consulting for sexual dysfunction.

Authors:  G Rastrelli; G Corona; M Tarocchi; E Mannucci; M Maggi
Journal:  J Endocrinol Invest       Date:  2016-01-05       Impact factor: 4.256

Review 7.  Which patients with sexual dysfunction are suitable for testosterone replacement therapy?

Authors:  A Morelli; G Corona; S Filippi; S Ambrosini; G Forti; L Vignozzi; M Maggi
Journal:  J Endocrinol Invest       Date:  2007-11       Impact factor: 4.256

Review 8.  The effect of 5α-reductase inhibitors on prostate growth in men receiving testosterone replacement therapy: a systematic review and meta-analysis.

Authors:  Yuanshan Cui; Huantao Zong; Chenchen Yang; Huilei Yan; Yong Zhang
Journal:  Int Urol Nephrol       Date:  2013-06-01       Impact factor: 2.370

9.  The benefits and risks of testosterone replacement therapy: a review.

Authors:  Nazem Bassil; Saad Alkaade; John E Morley
Journal:  Ther Clin Risk Manag       Date:  2009-06-22       Impact factor: 2.423

10.  Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations.

Authors:  C Wang; E Nieschlag; R Swerdloff; H M Behre; W J Hellstrom; L J Gooren; J M Kaufman; J-J Legros; B Lunenfeld; A Morales; J E Morley; C Schulman; I M Thompson; W Weidner; F C W Wu
Journal:  Eur J Endocrinol       Date:  2008-11       Impact factor: 6.664
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.